Apart from the inherent risks that unproven peptide therapies may pose,8 it may set a potentially dangerous precedent in which a drugs availability hinges on health market trends instead of clinical research, and could send the wrong message to the public
Curiously, CT2 that, in normal conditions, has a very narrow and specific tissue distribution, becomes widely expressed in cancers even originating from tissues in which CT2 is normally not present, further highlighting the carnitine role in human cancers
interestingly, Okui et al
These interconnected pathways demonstrate that ROS are not merely metabolic byproducts but active mediators of osteoclast development
Metabolic flexibilitythe ability to switch efficiently between carbohydrate and fat oxidationis arguably the most important metabolic attribute for ultra-distance performance